Oral vinorelbine to treat women with ectopic pregnancy: a phase 1 clinical safety and tolerability study

Affiliations

• ¹ Obstetric Diagnostics and Therapeutics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia; Mercy Perinatal, Mercy Hospital for Women, Melbourne, Victoria, Australia; Clinical Trials Unit, Department of Obstetrics and Gynaecology, The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia. Electronic address: prath1mak@yahoo.co.in.
• ² Obstetric Diagnostics and Therapeutics Group, Department of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Victoria, Australia; Mercy Perinatal, Mercy Hospital for Women, Melbourne, Victoria, Australia.
• ³ Mercy Perinatal, Mercy Hospital for Women, Melbourne, Victoria, Australia.
• ⁴ Clinical Trials Unit, Department of Obstetrics and Gynaecology, The Ritchie Centre, Hudson Institute of Medical Research, Melbourne, Victoria, Australia.
• ⁵ MRC Centre for Reproductive Health, Queen's Medical Research Institute, Edinburgh, United Kingdom.
• ⁶ New Zealand Institute for Advanced Study, Massey University, Albany, Auckland, New Zealand.
• ⁷ Monash University, Melbourne, Australia.
• ⁸ Department of Obstetrics and Gynaecology, Waitemata District Health Board, Auckland, New Zealand.
• ⁹ Institute of Innovation and Improvement, Waitemata District Health Board, Auckland, New Zealand.